[1]
E. A. Triyono, N. M. Rehatta, Nabilah, and F. Tan, “Clinical Profiles and Il-6 Level Analysis of Critical Covid-19 Patients Receiving Lopinavir-Ritonavir”, FMI, vol. 59, no. 2, pp. 92–98, Jun. 2023.